CAPA Peptide Analogues for Targeted Insect Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current insecticides are broad-spectrum and have detrimental environmental impacts, necessitating the development of target-specific, greener alternatives for controlling hemipteran and dipteran insects like aphids and fruit flies without affecting important pollinators.

Innovation Solution

Development of analogues of CAPA peptides with specific activity against hemipteran and dipteran insects, such as LVAFPRV and LYAFARV, which act as insecticidal compounds by contacting the insects topically or through substrates like plants, minimizing impact on pollinators like bees.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If broad-spectrum insecticides are used to control hemipteran and dipteran insects, then insect mortality increases, but environmental harm and impact on pollinators worsen

Engineering Contradiction:
Improveinsect mortalityVSAvoidenvironmental harm
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by designing neuropeptide analogues with specific amino acid sequences (e.g., LVAFPRV, LYAFARV) that are highly selective for hemipteran and dipteran insect receptors. This specificity ensures the insecticidal action is localized to target species while sparing pollinators like bees, thereby resolving the contradiction between effective insect control and environmental protection

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If wild-type CAPA peptides are used as insecticidal agents, then target-specificity is improved, but stability against proteases worsens

Engineering Contradiction:
Improvetarget-specificityVSAvoidprotease stability
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by systematically modifying the amino acid sequence of wild-type CAPA peptides to create analogues with enhanced protease stability. Specific substitutions at key positions (e.g., introducing N-methylated amino acids, modifying the C-terminal amide bond) increase resistance to proteolytic degradation while preserving receptor binding affinity and insecticidal activity against target species

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If neuropeptide analogues are developed for target-specific insect control, then environmental impact is reduced, but manufacturing complexity increases

Engineering Contradiction:
Improveenvironmental impactVSAvoidmanufacturing complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies this principle by developing neuropeptide analogues that can be synthesized through relatively simple chemical or biochemical methods, allowing for cost-effective production despite the specialized sequences required for target specificity. The modular nature of peptide synthesis enables scalable manufacturing while maintaining the environmental benefits of reduced non-target effects

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS20240373849A1Insect neuropeptide analogues
Publication Date: 2024.11.14 THE UNIV COURT OF THE UNIV OF GLASGOW
  • US20240373849A1 patent drawing
  • US20240373849A1 patent drawing
  • US20240373849A1 patent drawing

AI summary

The present invention relates to analogues of insect neuropeptides having activity against hemipteran and dipteran insects, such as aphids and fruit flies, and their use as insect control agents (e.g. insecticides) and plant protection agents.